Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients

• Status: Terminated
• Trial end date: 2006-03-01
• Target enrollment: 0
• Participant gender: Male

Summary

To investigate the long-term safety and tolerability of repeated doses of degarelix to prostate cancer patients

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ferring Pharmaceuticals

Criteria

Inclusion Criteria:

• Has completed study treatment in study FE200486 CS02.

• Has completed visit 16 in study FE200486 CS02.

• Has not met any withdrawal criteria up to and including visit 15 in FE200486 CS02